These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30686792)

  • 1. Discovery of meta-Amido Bromophenols as New Antitubercular Agents.
    Liang J; Tang YX; Tang XZ; Liang HJ; Gao Y; Fang C; Zhang TY; Yan M
    Chem Pharm Bull (Tokyo); 2019 Apr; 67(4):372-381. PubMed ID: 30686792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions.
    Zhang NN; Tang YX; Qian L; Gao YM; Liu ZY; Zou ZL; Zhang TY; Yan M
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800277. PubMed ID: 30698293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of (3-Benzyl-5-hydroxyphenyl)carbamates as New Antitubercular Agents with Potent In Vitro and In Vivo Efficacy.
    Cheng YJ; Liu ZY; Liang HJ; Fang CT; Zhang NN; Zhang TY; Yan M
    Molecules; 2019 May; 24(10):. PubMed ID: 31137832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro investigation of halogenated 1,3-bis(4-nitrophenyl)triazenide salts as antitubercular compounds.
    Torfs E; Vajs J; de Macedo MB; Cools F; Vanhoutte B; Gorbanev Y; Bogaerts A; Verschaeve L; Caljon G; Maes L; Delputte P; Cos P; Košmrlj J; Cappoen D
    Chem Biol Drug Des; 2018 Feb; 91(2):631-640. PubMed ID: 28845550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity.
    Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC
    Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant Mycobacterium tuberculosis.
    Krasavin M; Parchinsky V; Kantin G; Manicheva O; Dogonadze M; Vinogradova T; Karge B; Brönstrup M
    Bioorg Med Chem; 2017 Mar; 25(6):1867-1874. PubMed ID: 28214232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
    Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
    Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cationic quinazolin-4(3H)-one conjugated fullerene nanoparticles as antimycobacterial and antimicrobial agents.
    Patel MB; Harikrishnan U; Valand NN; Modi NR; Menon SK
    Arch Pharm (Weinheim); 2013 Mar; 346(3):210-20. PubMed ID: 23359525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of the bromophenols from the red alga Odonthalia corymbifera and some synthetic derivatives.
    Oh KB; Lee JH; Chung SC; Shin J; Shin HJ; Kim HK; Lee HS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):104-8. PubMed ID: 18053715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
    Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines.
    Sirisha K; Achaiah G; Reddy VM
    Arch Pharm (Weinheim); 2010 Jun; 343(6):342-52. PubMed ID: 20496343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
    Garg S; Shakya N; Srivastav NC; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2016 Nov; 24(21):5521-5533. PubMed ID: 27665179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.